Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme - Wikidata - awgldk - TriplyDB

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

http://www.wikidata.org/entity/Q33373293

about

Initial testing of VNP40101M (Cloretazine) by the pediatric preclinical testing program.Influence of glutathione and glutathione S-transferases on DNA interstrand cross-link formation by 1,2-bis(methylsulfonyl)-1-(2-chloroethyl)hydrazine, the active anticancer moiety generated by laromustine.Impact of imaging measurements on response assessment in glioblastoma clinical trials The role of cytotoxic chemotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline.Progression-free survival as a surrogate endpoint for overall survival in glioblastoma: a literature-based meta-analysis from 91 trials.Clinical activity of laromustine (Onrigin™) in hematologic malignancies.Evidence and Context of Use for Contrast Enhancement as a Surrogate of Disease Burden and Treatment Response in Malignant Glioma.

P2860

Q33718154-2EDB0DC8-4FDD-4D1E-AC6A-7419753A8290 Q34065933-5C6F8F89-7C0D-4758-8652-5477D56ADD08 Q34331328-D6B7D09D-69E8-41BB-95C7-49715369E99C Q38205133-102646A8-DB2D-4737-A526-49C2AFC51374 Q38720644-5551751F-C95C-42C6-AC19-E0E581879AAD Q42807419-B17AFF31-0A21-44DE-ABA7-F731CC4A0FFC Q47436703-D3CF4CD3-C88B-49AB-994B-D2CCC26C7272

P2860

Phase II study of Cloretazine for the treatment of adults with recurrent glioblastoma multiforme

http://www.wikidata.org/entity/Q33373293

description

2006 nî lūn-bûn

@nan

2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@ast

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@en

type

label

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@ast

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@en

prefLabel

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@ast

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@en

P1433

Q33373293-FF9668D9-73EF-4E5E-8D5A-1422317BB38D

P1476

Q33373293-B6BB9EC8-7E58-4EBF-9552-4BCBB533AD76

P2093

Q33373293-0B3FA3E8-2B10-4DEB-9FBB-F46B4776F3C5

Q33373293-35C0CA3C-1690-4445-9179-E64776A5E545

Q33373293-4DE48645-CE56-4E23-B5E5-DA0005D1CBA0

Q33373293-68B8590A-CBE8-4385-85D7-F92740A3075C

Q33373293-71EA641C-FDAF-4F86-BEDA-2DFB9445F5A6

Q33373293-A1D1B560-4A7E-4F3E-B13F-C0D3730AF2B4

Q33373293-BEB54415-4EF3-4DBA-A203-8FBC8571EE72

Q33373293-C6640447-B8FA-440D-AACF-208420B22EFB

P2860

Q33373293-090892D4-0832-49BF-9933-D3A65B74AA41

Q33373293-12CF93E5-79AB-4A0F-9403-BB08610F6983

Q33373293-334251AC-462B-422D-9C0C-0DED8B291D8C

Q33373293-36049807-1242-422C-90C3-D02DF94E578E

Q33373293-3A9FDC3C-AAF6-4460-95A3-860FC521960D

Q33373293-6642D90F-7305-47DE-9996-2AE8011A2E79

Q33373293-8D76145D-1DE1-4F3B-AB46-ACB4DF4E1173

Q33373293-A7ABA841-D495-4D3C-88A5-8C7A218E8BB7

Q33373293-ADCFD4A4-3A15-4CFC-9596-8E1C68634D4A

Q33373293-B006E23A-65FB-405E-BD4F-DAB83DC04F6D

P304

Q33373293-A1A35620-4BC2-4DDC-95EA-957FBF815FF2

P31

Q33373293-D590CEF2-758B-44C2-9F66-CFCF389B8072

P356

Q33373293-BFB8610D-2992-498F-AA7A-A628B5254C8E

P433

Q33373293-B8F4B279-6092-4741-AD0E-9D51662C6B68

P478

Q33373293-5A222BCE-DE24-4F3D-8F99-EF8DD8A15299

P50

Q33373293-4C942457-53E6-4C20-B083-4921EE0FB133

Q33373293-6F404E96-8070-44E9-926C-E58BB3493F0E

Q33373293-9DF7FFB5-B246-4E9E-BBF4-9B3A4EC4E391

Q33373293-C4758399-9848-4790-BA89-B6E125ED8EC3

Q33373293-F0A67CB2-04A9-4FC1-A9C7-0EB2627F2C3B

P577

Q33373293-535F119D-8445-4B75-88F8-E871B3C55D21

P5875

Q33373293-76249572-EC4F-43C8-A4B9-BAACA1E53C99

P698

Q33373293-2330EE68-FBD0-45D0-B94D-3336558D3061

P932

Q33373293-286F357E-6F78-4298-B70D-7624164381CF

P356

15228517-2006-022

P1433

P1476

Phase II study of Cloretazine ...... urrent glioblastoma multiforme

@en

P2093

Ann Cahill

http://www.w3.org/2001/XMLSchema#string

James E Herndon

http://www.w3.org/2001/XMLSchema#string

James J Vredenburgh

http://www.w3.org/2001/XMLSchema#string

Jennifer A Quinn

http://www.w3.org/2001/XMLSchema#string

Jeremy N Rich

http://www.w3.org/2001/XMLSchema#string

Kara Penne

http://www.w3.org/2001/XMLSchema#string

Michael A Badruddoja

http://www.w3.org/2001/XMLSchema#string

Sith Sathornsumetee

http://www.w3.org/2001/XMLSchema#string

P2860

Comparison of DNA lesions produced by tumor-inhibitory 1,2-bis(sulfonyl)hydrazines and chloroethylnitrosoureas

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Novel chemotherapeutic approaches to brain tumors.

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

Therapy of adult malignant brain tumors: what have the clinical trials taught us?

Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme.

The basis for current treatment recommendations for malignant gliomas.

A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.

Response criteria for phase II studies of supratentorial malignant glioma.

Differential inhibition of cellular glutathione reductase activity by isocyanates generated from the antitumor prodrugs Cloretazine and BCNU.

P304

70-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1215/15228517-2006-022

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Darell D. Bigner

Henry Seth Friedman

Annick Desjardins

David A Reardon

P577

2006-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6689824

http://www.w3.org/2001/XMLSchema#string

P698

17108065

http://www.w3.org/2001/XMLSchema#string

P932

1828104

http://www.w3.org/2001/XMLSchema#string